Masimo Wins IPR Patent Trial Vs Apple
https://ptacts.uspto.gov/ptacts/public-informations/petitions/1550005/download-documents?artifactId=170370051
Stifel Maintains Buy on Masimo, Raises Price Target to $170
Stifel analyst Rick Wise maintains Masimo (NASDAQ:MASI) with a Buy and raises the price target from $164 to $170.
Needham Reiterates Buy on Masimo, Maintains $173 Price Target
Needham analyst Mike Matson reiterates Masimo (NASDAQ:MASI) with a Buy and maintains $173 price target.
Reported Late Tuesday, ITC Judge Rules Apple Violated U.S. Trade Laws By Infringing Masimo Pulse Oximeter Patent
A United States Administrative Law Judge in Washington, D.C. ruled that Apple Inc. (NASDAQ:AAPL) violated Section 337 of the Tariff Act of 1930 as amended, by importing and selling within the United States certain Apple
Apple Watch Faces Potential Import Ban As US Judge Rules Against Tech Giant In Patent Infringement Case
Apple Inc.'s (NASDAQ: AAPL) smartwatches could face an import ban as a U.S.
$7.5 Million Bet On This Financial Services Stock? Check Out These 3 Stocks Insiders Are Buying
Although US stocks closed lower on Monday, there were a few notable insider trades.
New Prospective Study Finds That Masimo SpHb Noninvasive And Continuous Hemoglobin Monitoring Can Help Provide Effective Blood Management In Patients Undergoing Major Surgery
Masimo (NASDAQ:MASI) today announced the findings of a prospective, double-blinded, randomized, controlled trial published in the Journal of the College of Physicians and Surgeons Pakistan. In the study, Dr.
Earnings Scheduled For November 8, 2022
Companies Reporting Before The Bell
• Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.